Biologics for Stricturing Crohn's Diseases
Recruiting now
Conditions studied: The Efficacy of Biologics for Stricturing Crohn's Diseases
In brief
Recent researches have reported that biologics might be also effective for stricturing CD. However, the data were largely retrospective. Prospective studied are needed for evaluate the efficacy of biologics for stricturing Crohn's diseases.
Key facts
- Study ID
- NCT05645055
- Run by
- Jinling Hospital, China
- People needed
- 200
- Starts
- 2021-01-01
- Expected to finish
- 2029-01-01
- Last updated by the study team
- 2023-05-11
Who can join
Age: 16 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- patients with stricturing Crohn's diseases
- no surgical indication
- patients with asymptomatic penetrating diseases
- written consent acquired
You may not qualify if…
- patients with surgical indication
- patients with symptomatic penetrating diseases
- contraindication of biologics
- anticipating other trial
Where it is running
- Department of General Surgery, Jinling hosptal,Medical School of Nanjing University — Nanjing, Jiangsu, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.